• Substance P: Applied Workflows and Troubleshooting in Pain R

  2026-07-20

  Substance P enables precise dissection of pain, inflammation, and neuroimmune pathways with robust, reproducible protocols. Discover validated workflows, innovative spectral solutions, and expert troubleshooting tips that maximize data fidelity in CNS and immunology research.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineering Immunity Beyond

  2026-07-20

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables precise immunotherapy research by overcoming extrahepatic delivery barriers. This in-depth analysis reveals the molecular innovations and practical protocols that set this cytokine mRNA apart.

• KPT330 Enhances CRISPR-Cas9 Precision via mRNA Nuclear Expor

  2026-07-19

  The reference study demonstrates that the selective inhibitor KPT330 increases the specificity of CRISPR-Cas9 genome and base editing by regulating nuclear export of Cas9 mRNA rather than directly inhibiting the protein. This work provides a new strategy to improve precision in genome editing, with implications for reducing off-target effects in mammalian cell applications.

• Calpeptin: Calpain Inhibitor Workflows for Pulmonary Fibrosi

  2026-07-18

  Calpeptin, a nanomolar-potency calpain inhibitor from APExBIO, uniquely empowers fibrosis and inflammation modeling with highly specific, reproducible inhibition of calpain 1. This article translates bench-to-publication workflows, advanced troubleshooting, and protocol optimization strategies for impactful pulmonary fibrosis and cell death studies.

• Reliable RNA Synthesis for Assays: HyperScribe™ T7 Kit (SKU

  2026-07-17

  This article addresses core laboratory challenges in generating high-quality RNA for cell viability, proliferation, and cytotoxicity assays, focusing on the HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU K1047). Using scenario-driven analysis and literature-backed insights, we demonstrate how this kit ensures consistent results, robust yields, and compatibility with advanced assay needs.

• JNJ-10198409 in Antiangiogenic Research: Deep Mechanistic In

  2026-07-17

  Explore how JNJ-10198409, a potent platelet-derived growth factor receptor inhibitor, enables advanced antiangiogenic and antiproliferative research. This article uniquely integrates signaling insights and protocol precision to push the boundaries of cancer and fibrosis studies.

• Targeted mRNA Nanoparticles Restore BBB Post-Stroke via Micr

  2026-07-16

  A recent study demonstrates that M2 microglia-targeting lipid nanoparticles (MLNPs) delivering interleukin-10 mRNA can significantly ameliorate blood–brain barrier (BBB) disruption following ischemic stroke by promoting reparative microglial phenotypes. This approach offers a promising, time-extended strategy for poststroke neurological protection and could reshape mRNA therapeutic delivery for central nervous system disorders.

• AhR Antagonism Mitigates MEHP-Induced Ovarian Toxicity in Mi

  2026-07-16

  This study reveals that the aryl hydrocarbon receptor (AhR) mediates the ovarian toxicity of mono(2-ethylhexyl) phthalate (MEHP), a key phthalate metabolite, impairing follicle growth and estrogen production in mouse antral follicles. Importantly, the use of the AhR antagonist CH 223191 partially rescues these effects, highlighting AhR as a mechanistic target for environmental toxicology and reproductive research.

• (R)-MG132: Unmatched Negative Control in Proteasome Research

  2026-07-15

  (R)-MG132, the functionally inactive MG-132 enantiomer, is the gold-standard negative control for validating proteasome-dependent mechanisms in cell-based assays. By discriminating true on-target effects from off-target artifacts, it enables rigorous and reproducible ubiquitin-proteasome system research.

• Phosbind Acrylamide: Advancing Translational Phosphoproteomi

  2026-07-15

  Explore how Phos binding reagent (Phosbind) acrylamide empowers translational researchers to dissect phosphorylation-driven signaling, with strategic insight into workflow optimization, reference to the latest plant signaling breakthroughs, and a critical look at the competitive landscape.

• (-)-JQ1: Benchmark Stereoisomer Negative Control in Epigenet

  2026-07-14

  (-)-JQ1 is a rigorously validated JQ1 stereoisomer widely used as a negative control in BET bromodomain inhibition research. It provides essential assay specificity in epigenetics and cancer biology studies, supporting the accurate interpretation of BRD4-dependent effects.

• AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I

  2026-07-14

  This study elucidates a two-phase mechanism by which AIBP-LRP2–mediated HDL uptake limits the expansion of CXCR4+ stemlike capillary endothelial cells and thus restricts collateral circulation in ischemic vascular disease. These insights reveal new molecular targets for therapeutic modulation of vascular remodeling and revascularization.

• ATRX Loss Sensitizes High-Grade Glioma to RTK/PDGFR Inhibiti

  2026-07-13

  This article discusses recent evidence that ATRX-deficient high-grade glioma cells display heightened sensitivity to receptor tyrosine kinase (RTK) and PDGFR inhibitors. These findings suggest a potential precision-medicine approach for glioma patients and highlight the need to consider ATRX status in clinical trial stratification and therapeutic strategy.

• EZ Cap™ Cas9 mRNA (m1Ψ): Leveraging mRNA Engineering for Saf

  2026-07-13

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) redefines genome editing precision and safety through advanced mRNA engineering, including Cap1 structure and m1Ψ modification. This article examines nuclear export regulation and immune evasion, offering unique scientific insights for researchers seeking next-generation CRISPR-Cas9 solutions.

• (+)-Bicuculline: Technical Guidance for GABAA Antagonist Wor

  2026-07-12

  (+)-Bicuculline is a competitive GABAA receptor antagonist widely used in neuroscience research to interrogate inhibitory neurotransmission and modulate synaptic NMDA receptor signaling. It is not suitable for diagnostic or clinical use and requires strict adherence to solubility and storage protocols for reliable results.

552 records 11/37 page Previous Next First page 上5页 1112131415 下5页 Last page